173 Cystic fibrosis patients’ performance on Modified Shuttle Walk Test  by Karapanagiotis, S. et al.
Posters 9. Physiotherapy S91
173 Cystic ﬁbrosis patients’ performance on Modiﬁed Shuttle Walk
Test
S. Karapanagiotis1, S. Gambazza1, A. Brivio1, C. Colombo1. 1Fondazione IRCCS
Ca’ Granda Ospedale Maggiore Policlinico, Cystic Fibrosis, Milan, Italy
Background: The Modiﬁed Shuttle Walk Test (MSWT) is a frequently used ﬁeld
test to identify deﬁciency in cardiorespiratory ﬁtness, to evaluate patients for lung
transplant and to establish interventions aimed at improving exercise capacity. It is a
valid and reliable measure of exercise performance in CF, it is easily administered,
inexpensive and can be conducted in limited space.
Objectives: To analyse CF patients’ performance on the MSWT.
Methods: CF adolescents and adults were recruited for MSWT within 48h before
hospital discharge. Lung function was categorized according to the CFF. Distance
walked, cardiac overload and oxygen saturation (SpO2) were evaluated.
Results: All values are mean (SD) if not otherwise reported. 41 patients (48.8%
females) aged 18.4 yrs (4.47), with FEV1% pred. of 78% (27.23) were enrolled.
The MSWT distance was 807.7 m (95%CI 725.95–889.42), SpO2 93.3% (2.72),
maximum heart rate (HRmax) 167.5 (15.6) bpm. Median values (IQR) for patients
reported Borg scale dyspnea increased from 0 (1) at baseline to 5 (3) at the end of the
test. Corresponding ﬁgures for fatigue were 0 (0.5) and 4 (5), respectively; 70.7%
of patients achieved HRmax above 80% of pred.HRmax. There was a signiﬁcant
difference in mean MSWT distance among FEV1% categories (p = 0.002), whereas
this was not the case for HRmax and FEV1% categories (p = 0.104). The MWST
distance correlated with FEV1%pred. (r = 0.3699, p = 0.017).
Conclusion: Most of the patients reached their maximal cardiovascular capacity.
The remaining were probably limited by the severity of lung disease as supported
by the fact that lung function impairment affected their exercise performance.
174 Are changes in Modiﬁed Shuttle Walk Test performance related
to changes in clinical status in CF children and adolescents?
A. Zanini1, C. Cazzarolli1, C. Tartali1, R. Bellini1, B. Longhini1, A. Meschi1,
B.M. Assael1. 1Azienda Ospedaliera Universitaria Integrata Verona, Cystic
Fibrosis Centre, Verona, Italy
Background: The Modiﬁed Shuttle Walk Test (MSWT) is a validated ﬁeld test used
to assess exercise tolerance in patients with Cystic Fibrosis (CF). Studies conﬁrmed
its utility in evaluating improvements after an intravenous antibiotic treatment in
both CF adults and children. To date, its relation to longer term clinical course of
CF paediatric patients has not be determined.
Aims: To determine changes over time in the MSWT performance in CF children
and adolescents.
Methods: 34 CF children and adolescents (19 F) (mean age 12.3 yrs, range
6−17 and FEV1%pred 77.5, range 48–103) were recruited. MSWT performance,
spirometry, anthropometric measures were evaluated at recruitment and after 1.5
year. Clinical status was evaluated by number and days of hospitalization in the
same period compared to the previous year.
Results: Lung function did not signiﬁcantly change over time, but days (p = 0.03)
and number (p = 0.02) of hospitalizations signiﬁcantly increased in the observation
period compared to the previous year. Height increased signiﬁcantly (p< 0.0001).
Both MSWT (p = 0.001) and height-corrected MSWT performance (p = 0.03)
improved signiﬁcantly. The improvement in MSWT distance was not signiﬁ-
cantly correlated with changes in FEV1%pred (p = 0.38), CV%pred (p = 0.38) and
FEF25−75%pred (p = 0.82).
Conclusion: Our data indicate that improvements in MSWT in children and
adolescents are determined by growth and do not necessarily reﬂect clinical status.
Longer studies are needed to conﬁrm its validity in predicting clinical deterioration
and identifying patients at higher risk.
175 Exercise intensity during interactive video game
S. Karapanagiotis1, S. Gambazza1, A. Brivio1, C. Colombo1. 1Fondazione IRCCS
Ca’ Granda Ospedale Maggiore Policlinico, Cystic Fibrosis, Milan, Italy
Background: Interactive video games have been introduced as an exercise inter-
vention to improve aerobic ﬁtness in cystic ﬁbrosis (CF) patients.
Objectives: To further investigate its clinical applications we used the commercially
available Wii® gaming console and we therefore determined the intensity of
exercise.
Methods: Patients admitted for pulmonary exacerbation were eligible to participate
in this study once they were considered clinically stable. The game chosen was Just
Dance, a dancing game of the Wii® console. Energy expenditure in metabolic
equivalents (METs) was measured using an activity monitor during the time-play.
Activity was categorised according to the recommendations for children and youth
in light (<4.7 METs), moderate (4.8−7.1 METs), vigorous (7.2–10.1 METs) and
near maximal to maximal (>10.2 METs).
Results: The 9 consecutive patients so far enrolled had a mean age of 17.33 yrs
(SD 5.24), FEV1%pred. 87.80 (SD 22.60), BMI percentile 34.69 (SD 17.30). The
95%CI of the game’s intensity was 4.69–5.63 METs. The mean METs and calories
consumed in every difﬁculty level were (1) 4.52 METs, 4.28 cal/min; (2) 5.29 METs,
5.18 cal/min; (3) 5.66 METs, 5.35 cal/min. No signiﬁcant difference in METs
emerged between the three levels (p< 0.5).
Conclusion: The intensity of exercise achieved when using an interactive gaming
console in CF patients can be considered as light to moderate and therefore can con-
tribute to the promotion and maintenance of physical ﬁtness during hospitalization
for an acute exacerbation.
176 Assessment of exercise capacity in patients with cystic ﬁbrosis
A. Sovtic1, P. Minic1,2. 1Mother and Child Health Institute of Serbia, Department
of Pulmonology, Belgrade, Serbia; 2University of Belgrade, School of Medicine,
Belgrade, Serbia
Objectives: We evaluated the correlation of lung function, nutritional status, res-
piratory muscle strength and structural changes on chest radiography with exercise
tolerance during progressive cardiopulmonary exercise testing (CPET) in patients
with CF.
Methods: Spirometry, whole body plethysmography and CPET were done. A
catheter was placed in the brachial artery for blood gas analysis and lactate
concentrations during the test. Respiratory muscle strength was expressed as
maximal inspiratory and expiratory pressures. Standard chest radiographies were
scored according to modiﬁed Chrispin-Norman score.
Results: Study was conducted in Mother and Child Health Institute of Serbia.
Data collected from 64 patients with CF (mean age 17.1 years) were included in
the analysis. The FEV1 signiﬁcantly correlates with peak exercise capacity (Wpeak
% predicted) in patients with CF (p< 0.001). The RV/TLC is the most signif-
icant predictive factor of ventilatory limitation (R2=0.524; B=0.003; p< 0.001).
Hypoxemia and oxygen desaturation on Wpeak were present in patients with
decreased lung function (p< 0.001) and malnutrition (p = 0.006). There was no
statistically signiﬁcant difference in Wpeak between groups of patients with different
respiratory muscle strength. Patients with the highest values of modiﬁed Chrispin-
Norman scores had the most prominent exercise limitation during progressive CPET
(p = 0.001).
Conclusion: Patients with the most severe CF lung disease have signiﬁcant exercise
intolerance. Annual CPET would enable complete clinical evaluation and precise
and systematic planning of individualized rehabilitation and lung transplantation
protocols.
